ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,936.33
      1.66%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Magenta Therapeutics Inc (MGTA)

      7. Magenta Therapeutics Inc (MGTA) News

      MGTA

      Magenta Therapeutics (MGTA)

      Magenta Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MGTA
      DateTimeSourceHeadlineSymbolCompany
      04/11/20244:10PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MGTAMagenta Therapeutics Inc
      04/11/20244:09PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MGTAMagenta Therapeutics Inc
      04/11/20244:05PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MGTAMagenta Therapeutics Inc
      04/01/20246:34PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
      04/01/20246:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
      03/28/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MGTAMagenta Therapeutics Inc
      03/21/20245:10PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MGTAMagenta Therapeutics Inc
      03/21/20245:02PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
      03/21/20244:07PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MGTAMagenta Therapeutics Inc
      03/21/20244:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
      02/14/20244:16PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
      02/09/20244:10PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
      02/07/20244:52PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
      02/02/20244:32PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MGTAMagenta Therapeutics Inc
      01/31/202412:11PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:MGTAMagenta Therapeutics Inc
      01/26/20244:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
      01/26/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
      01/26/20244:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
      01/24/20246:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
      01/24/20245:26PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
      01/22/20247:34AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
      01/08/20248:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
      12/21/20235:08PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
      12/21/20234:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
      11/09/20234:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
      11/09/20234:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
      10/25/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
      10/04/20234:55PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MGTAMagenta Therapeutics Inc
      10/04/20234:20PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MGTAMagenta Therapeutics Inc
      09/25/20234:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:MGTA